More importantly, we compared MEG3 expression in primary hepatocytes from healthy individuals and patients suffering from earlier steatosis or later-stage fibrosis and revealed the reverse correlation between MEG3 level and the severity of NAFLD, evidencing the clinical relevance of MEG3 in NAFLD. This evidence concerns the gene MEG3 and steatosis.